Patent Frameworks For Self-Learning Computational Biology Models

21 Mar 2026 --
0 Comments

🤖 1. Legal Foundations of Patenting Self-Learning Computational Biology Models

Self-learning computational biology models include:

AI-driven drug discovery models
Machine learning models predicting gene expression
Deep learning for protein folding (e.g., DeepMind AlphaFold)
Simulation tools for metabolic pathways or microbiome interactions

Patentability criteria:

Novelty – The model or algorithm must be new.
Inventive step (non-obviousness) – Must show technical innovation beyond standard AI techniques.
Industrial applicability – Must have a practical application in biology or medicine.

Challenges:

Algorithms themselves are abstract ideas, often excluded from patentability in many jurisdictions.
AI-generated inventions raise questions: Who is the inventor, the programmer, or the AI?
Computational biology involves data-driven insights, which may or may not be patentable depending on jurisdiction.

Key international frameworks:

World Intellectual Property Organization
TRIPS Agreement
National patent laws (e.g., US Patent Act 35 USC statute"], Patents Act 19700, USA)**
Court: Supreme Court of the United States

Facts:

Chakrabarty engineered bacteria capable of breaking down crude oil.

Issue:

Can a genetically modified living organism be patented?

Judgment:

Yes, anything “made by man” is patentable.

Relevance:

Sets precedent for engineered biological outputs from AI models, e.g., novel proteins predicted by computational biology tools.

2. Alice Corp. v. CLS Bank (2014, USA)

Court: Supreme Court of the United States

Facts:

Patent claimed a computerized method for mitigating financial risk.

Issue:

Are abstract ideas implemented on computers patentable?

Judgment:

Abstract ideas alone are not patentable, even if computer-implemented.

Relevance:

AI-driven computational biology models must have specific technical applications beyond just data processing to be patentable.

3. Enfish, LLC v. Microsoft Corp. (2016, USA)

Court: United States Court of Appeals for the Federal Circuit

Facts:

Patents for a self-referential database structure.

Issue:

Does a software model that improves computer functionality qualify for patentability?

Judgment:

Yes, if it improves computer performance rather than being abstract.

Relevance:

For computational biology, AI models optimizing data processing for protein folding or gene prediction could be patentable.

4. University of California v. Broad Institute (CRISPR Patent Dispute, 2012–2020)

Courts: US Patent Office & Federal Circuit

Facts:

Competing patents over CRISPR-Cas9 gene-editing techniques.

Issue:

Who has rights to pioneering gene-editing methods?

Judgment:

Mixed outcomes; Broad Institute awarded some patents.

Relevance:

Computational biology models that generate novel gene-editing strategies can be patented, but ownership disputes are common.

5. Thaler v. USPTO (DABUS AI Inventor Case, 2020–2022, USA/UK/South Africa)

Courts: US, UK, South Africa

Facts:

Dr. Stephen Thaler applied for patents listing an AI system (DABUS) as inventor.

Issue:

Can an AI system be recognized as an inventor?

Judgment:

US: ❌ AI cannot be an inventor.
UK: ❌
South Africa: ✅ (patent allowed, AI as inventor)

Relevance:

Self-learning computational biology models cannot currently be listed as inventors in most countries, but this is changing internationally.

6. Merck v. Integra (2005, USA)

Court: Supreme Court of the United States

Facts:

Dispute over use of patented compounds in preclinical drug testing.

Issue:

Does experimental use exempt infringement?

Judgment:

Using a patented invention for preclinical research can be exempt, but only for experimental purposes.

Relevance:

Computational biology startups using patented biological datasets or models for R&D may rely on experimental-use exceptions.

7. University of Utah Research Foundation v. Ambry Genetics (Biotech Software, 2018)

Facts:

Patent claimed computational method to detect gene mutations.

Issue:

Are algorithmic models for gene analysis patentable?

Judgment:

Patent upheld because the model produced concrete, useful biological information, not just abstract computation.

Relevance:

Reinforces that self-learning biology models need to demonstrate practical application in biological research or therapy.

🌐 3. Challenges for Startups

Algorithm vs. Application:
- Pure algorithms (ML, deep learning) are not patentable unless tied to specific biological applications.
Inventorship:
- Most jurisdictions require a human inventor, limiting AI-generated patents.
Data Ownership:
- AI models often rely on public or proprietary biological datasets; patenting requires clear rights to the data.
International Variability:
- US, EU, and India differ in software and biotech patent standards.
Ethical Considerations:
- Using AI to predict human or animal genes may raise ethical and regulatory questions.

🧠 4. Key Takeaways

Patentable: AI-driven models that produce novel, practical biological inventions (proteins, metabolic pathways, drug candidates).
Not patentable: Abstract algorithms, general-purpose AI, or purely data-driven predictions without technical application.
Ownership: Human inventor is required in most countries; AI as inventor is not widely accepted.
Legal strategy: Document human contribution, technical improvement, and dataset ownership.